Woman and Man | Between 18 years et 80 years
- | Country :
- France
- | organs :
- Côlon ou Rectum (colorectal)
- Métastases hépatiques
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer.
Scientific Abstract
en cours d'intégration;